Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 16 September 2020. Oliver Bisazza.

Executive Summary

The medtech industry wants the European Commission to allow virtual audits so companies can gain initial audit certificates against the Medical Device Regulation and In Vitro Diagnostic Regulation in timely fashion during the COVID-19 pandemic. Oliver Bisazza, director of regulations and industrial policy for MedTech Europe, commented on the issue.

“If we don’t allow virtual audits, we are not signaling that companies are rewarded for doing the right thing" – Oliver Bisazza, director of regulations and industrial policy, MedTech Europe

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142740

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel